Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
An open-label, dose escalation and expansion clinical trial to evaluate the safety,
tolerability and PK of HMPL-689 in patients with relapsed or refractory lymphomas